Role of Urinary Matrix Metalloproteinase-7 (MMP-7) as an Early Marker of Renal Dysfunction in Diabetic Individuals: A Cross-Sectional Study.

Autor: Sarangi R; Biochemistry, Kalinga Institute of Medical Sciences, Bhubaneswar, IND., Sahu D; Biochemistry, Kalinga Institute of Medical Sciences, Bhubaneswar, IND., Rout NK; Nephrology, Kalinga Institute of Medical Sciences, Pradyumna Bal Memorial Hospital, Bhubaneswar, IND., Padarabinda Tripathy K; General Medicine, Kalinga Institute of Medical Sciences, Bhubaneswar, IND., Patra S; Biochemistry, Kalinga Institute of Medical Sciences, Bhubaneswar, IND., Bahinipati J; Biochemistry, Kalinga Institute of Medical Sciences, Bhubaneswar, IND., Sahoo JP; Pharmacology, Kalinga Institute of Medical Sciences, Bhubaneswar, IND.
Jazyk: angličtina
Zdroj: Cureus [Cureus] 2024 Aug 07; Vol. 16 (8), pp. e66392. Date of Electronic Publication: 2024 Aug 07 (Print Publication: 2024).
DOI: 10.7759/cureus.66392
Abstrakt: Background and Objectives: The matrix metalloproteinase 7 (MMP-7) level gets heightened in the urine samples of diabetic individuals with impaired renal function. Renal biopsy is seldom offered because of its invasive nature. These concerns spurred the investigation of relationships between urine MMP-7 levels and the renal function of diabetic individuals. Studies exploring this aspect are scarce. We aimed to evaluate the glycemic and renal parameters of female and male individuals with or without type 2 diabetes mellitus (T2DM) or kidney disease. We also assessed the correlation of urine MMP-7 with various parameters.
Methods: This prospective, analytical, cross-sectional study was conducted at Kalinga Institute of Medical Sciences (KIMS), Bhubaneswar, India, from February 2020 to January 2023. Female and male individuals 18-85 years of age diagnosed with either T2DM, hypertension, or kidney disease were assessed for their glycemic indices and renal parameters. Those with both renal disease and T2DM were placed in group A. The diabetic individuals without kidney disease constituted group B. People in group C had neither kidney disease nor T2DM. Patients in group D had kidney disease but were not diabetics. The parameters of the male and female participants in each of the four groups were assessed and compared, including: age, body mass index (BMI), fasting blood sugar (FBS), glycosylated hemoglobin (HbA1c), serum urea, serum creatinine, estimated glomerular filtration rate (eGFR), urine albumin, urine creatinine, urine albumin-creatinine ratio (ACR), serum sodium, serum potassium, and urine MMP-7 levels. Furthermore, we correlated urine MMP-7 with all these traits. We used R software (version 4.4.0, Vienna, Austria) for data analysis.
Results: Two hundred eighty-seven (87.5%) of the 328 individuals we screened were eligible. Of them, group A had the maximum number (94) of participants, followed by B (75), C (65), and D (53). Males comprised 60.3% (n = 173) of the study population. The median age of the participants was 52.0 (44.0-61.1) years. The intergroup variations were statistically significant (p < 0.001) owing to their glycemic status and renal function. The gender-basis comparison of FBS and HbA 1c yielded non-significant differences. On the contrary, assessment of the renal parameters revealed significant differences (p < 0.001) between females and males. The study population had a median urine MMP-7 level of 19.9 (1.1-50.5) µg/L. Significant associations with urine MMP-7 were found with serum creatinine (r = 0.91, p < 0.001), urine ACR (r = 0.86, p < 0.001), and eGFR (r = -0.84, p < 0.001).
Conclusion: Our study portrayed that male diabetics, in comparison to female diabetics, had greater levels of urine ACR, urine MMP-7, eGFR, and serum creatinine. Moreover, urine ACR, eGFR, and serum creatinine strongly correlated with the urine MMP-7 level.
Competing Interests: Human subjects: Consent was obtained or waived by all participants in this study. Institutional Ethics Committee of Kalinga Institute of Medical Sciences (KIMS), Bhubaneswar, India issued approval KIIT/KIMS/IEC/211/2020 dated January 16, 2020. Animal subjects: All authors have confirmed that this study did not involve animal subjects or tissue. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.
(Copyright © 2024, Sarangi et al.)
Databáze: MEDLINE